ATE360004T1 - Imidazopyridine, -pyrimidine und -triazine als gaba-a alpha 5 rezeptor subtyp liganden zur verbesserung kognitiver eigenschaften - Google Patents
Imidazopyridine, -pyrimidine und -triazine als gaba-a alpha 5 rezeptor subtyp liganden zur verbesserung kognitiver eigenschaftenInfo
- Publication number
- ATE360004T1 ATE360004T1 AT02779772T AT02779772T ATE360004T1 AT E360004 T1 ATE360004 T1 AT E360004T1 AT 02779772 T AT02779772 T AT 02779772T AT 02779772 T AT02779772 T AT 02779772T AT E360004 T1 ATE360004 T1 AT E360004T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- sup
- alkyl
- heteroaryl
- halogen
- Prior art date
Links
- 239000003446 ligand Substances 0.000 title abstract 2
- 230000001149 cognitive effect Effects 0.000 title 1
- 150000005232 imidazopyridines Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 229910052736 halogen Inorganic materials 0.000 abstract 5
- 150000002367 halogens Chemical class 0.000 abstract 5
- 125000001072 heteroaryl group Chemical group 0.000 abstract 5
- 125000000623 heterocyclic group Chemical group 0.000 abstract 3
- 239000004215 Carbon black (E152) Substances 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229930195733 hydrocarbon Natural products 0.000 abstract 2
- 150000002430 hydrocarbons Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 102000004300 GABA-A Receptors Human genes 0.000 abstract 1
- 108090000839 GABA-A Receptors Proteins 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 230000019771 cognition Effects 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Cosmetics (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0128499.1A GB0128499D0 (en) | 2001-11-28 | 2001-11-28 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE360004T1 true ATE360004T1 (de) | 2007-05-15 |
Family
ID=9926615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02779772T ATE360004T1 (de) | 2001-11-28 | 2002-11-27 | Imidazopyridine, -pyrimidine und -triazine als gaba-a alpha 5 rezeptor subtyp liganden zur verbesserung kognitiver eigenschaften |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20060040940A1 (de) |
| EP (1) | EP1451161B1 (de) |
| JP (1) | JP2005518369A (de) |
| AT (1) | ATE360004T1 (de) |
| AU (1) | AU2002343110B2 (de) |
| CA (1) | CA2468893A1 (de) |
| DE (1) | DE60219672T2 (de) |
| ES (1) | ES2284941T3 (de) |
| GB (1) | GB0128499D0 (de) |
| WO (1) | WO2003048132A1 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1880998A1 (de) * | 2003-07-25 | 2008-01-23 | Neurogen Corporation | Imidazo-Pyrimide und Triazolo-Pyrimide: Benzodiazepin-Rezeptorliganden |
| CN100457756C (zh) * | 2003-07-25 | 2009-02-04 | 神经能质公司 | 咪唑-嘧啶类及三唑-嘧啶类:苯并二氮平受体配体 |
| KR20060098425A (ko) | 2003-07-25 | 2006-09-18 | 뉴로젠 코포레이션 | 이미다조-피리미딘 및 트리아졸로-피리미딘: 벤조디아제핀수용체 리간드 |
| US7329662B2 (en) | 2003-10-03 | 2008-02-12 | Hoffmann-La Roche Inc. | Pyrazolo-pyridine |
| GB0412769D0 (en) | 2004-06-08 | 2004-07-07 | Novartis Ag | Organic compounds |
| ATE460417T1 (de) | 2005-03-23 | 2010-03-15 | Hoffmann La Roche | Acetylenylpyrazolopyrimidinderivate als mglur2- antagonsten |
| ES2340321T3 (es) | 2005-09-27 | 2010-06-01 | F.Hoffmann-La Roche Ag | Oxadiazolilpirazolo-pirimidinas, como antagonistas de mglur2. |
| WO2008027812A2 (en) | 2006-08-28 | 2008-03-06 | Forest Laboratories Holdings Limited | Imidazopyridine and imidazopyrimidine derivatives |
| MX2009006704A (es) | 2006-12-22 | 2009-06-30 | Astex Therapeutics Ltd | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. |
| MX2009006706A (es) | 2006-12-22 | 2009-07-02 | Astex Therapeutics Ltd | Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos. |
| GB0720041D0 (en) | 2007-10-12 | 2007-11-21 | Astex Therapeutics Ltd | New Compounds |
| GB0720038D0 (en) | 2007-10-12 | 2007-11-21 | Astex Therapeutics Ltd | New compounds |
| JP5456681B2 (ja) * | 2007-10-17 | 2014-04-02 | ノバルティス アーゲー | ＡＬＫ阻害剤として有用なイミダゾ［１，２−ａ］ピリジン誘導体 |
| US20110112135A1 (en) * | 2007-12-21 | 2011-05-12 | Singhaus Jr Robert Ray | Imidazo [1,2-A] Pyridine Compounds |
| GB0810902D0 (en) | 2008-06-13 | 2008-07-23 | Astex Therapeutics Ltd | New compounds |
| US8222246B2 (en) | 2009-04-02 | 2012-07-17 | Hoffmann-La Roche Inc. | Substituted isoxazoles |
| GB0906470D0 (en) | 2009-04-15 | 2009-05-20 | Astex Therapeutics Ltd | New compounds |
| GB0906472D0 (en) | 2009-04-15 | 2009-05-20 | Astex Therapeutics Ltd | New compounds |
| US8785435B2 (en) | 2011-10-20 | 2014-07-22 | Hoffmann-La Roche Inc. | Solid forms |
| US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
| EP2968299B1 (de) | 2013-03-15 | 2021-01-20 | Global Blood Therapeutics, Inc. | Verbindungen und verwendungen davon zur modulation von hämoglobin |
| EP3919056B1 (de) | 2013-03-15 | 2024-08-28 | Global Blood Therapeutics, Inc. | Verbindungen und verwendungen davon zur modulation von hämoglobin |
| GB201321732D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| GB201321736D0 (en) * | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| SG10201911662YA (en) | 2014-02-07 | 2020-02-27 | Global Blood Therapeutics Inc | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
| HUE072191T2 (hu) | 2015-12-04 | 2025-10-28 | Global Blood Therapeutics Inc | A 2-hidoxi-6-((2-(1-izopropil-1H-pirazol-5-il)piridin-3-il)metoxi)benzaldehid adagolási rendje |
| CN111936136B (zh) | 2017-11-14 | 2024-07-05 | 儿童医学中心公司 | 新咪唑并嘧啶化合物及其用途 |
| US11730810B2 (en) | 2017-11-14 | 2023-08-22 | Children's Medical Center Corporation | Composition comprising an antigen and a substituted imidazo[1,2-a]pyrimidine for enhancing human immune response |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9503601D0 (en) * | 1995-02-23 | 1995-04-12 | Merck Sharp & Dohme | Method of treatment and method of manufacture of medicament |
| ATE236904T1 (de) * | 1996-07-25 | 2003-04-15 | Merck Sharp & Dohme | Substituierte triazolo-pyridazin-derivate als liganden von gaba-rezeptoren |
| EP0915877A1 (de) * | 1996-07-25 | 1999-05-19 | MERCK SHARP & DOHME LTD. | Substituierte triazolo-pyridazinderivate als inverse agonisten des gaba-a alpha-5 rezeptor subtyps |
| CA2288789C (en) * | 1997-05-08 | 2009-07-21 | Merck Sharp & Dohme Limited | Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as gaba alpha 5 ligands |
| CZ291302B6 (cs) * | 1998-02-25 | 2003-01-15 | Merck Sharp & Dohme Limited | Substituovaný 1,2,4-triazolo[3,4-a]ftalazinový derivát |
| GB9824897D0 (en) * | 1998-11-12 | 1999-01-06 | Merck Sharp & Dohme | Therapeutic compounds |
| GB9927687D0 (en) * | 1999-11-23 | 2000-01-19 | Merck Sharp & Dohme | Therapeutic agents |
| US6355638B1 (en) * | 1999-11-25 | 2002-03-12 | Merck Sharp & Dohme Ltd. | Pyrazolo[1,5-d][1,2,4] triazines for enhancing cognition |
| JP2004501109A (ja) * | 2000-05-24 | 2004-01-15 | メルク シャープ エンド ドーム リミテッド | Ｇａｂａ受容体に対するリガンドとしての３−フェニル−イミダゾ−ピリミジン誘導体 |
| GB0017543D0 (en) * | 2000-07-17 | 2000-09-06 | Merck Sharp & Dohme | Therapeutic agents |
| GB0017518D0 (en) * | 2000-07-17 | 2000-08-30 | Merck Sharp & Dohme | Therapeutic agents |
| CA2427779A1 (en) * | 2000-11-10 | 2002-05-16 | Merck Sharp & Dohme Limited | Imidazo-triazine derivatives as ligands for gaba receptors |
| GB0117277D0 (en) * | 2001-07-16 | 2001-09-05 | Merck Sharp & Dohme | Therapeutic agents |
| TWI248936B (en) * | 2001-03-21 | 2006-02-11 | Merck Sharp & Dohme | Imidazo-pyrimidine derivatives as ligands for GABA receptors |
| GB0125086D0 (en) * | 2001-10-18 | 2001-12-12 | Merck Sharp & Dohme | Novel compounds |
| GB0225501D0 (en) * | 2002-11-01 | 2002-12-11 | Merck Sharp & Dohme | Therapeutic agents |
| US7485640B2 (en) * | 2002-11-06 | 2009-02-03 | Merck Sharp & Dohme Limited | Imidazopyrazinones as GABA-A receptor anxiolytics |
| US6967255B2 (en) * | 2004-02-06 | 2005-11-22 | Industrial Technology Research Institute | Phenanthrene compounds |
-
2001
- 2001-11-28 GB GBGB0128499.1A patent/GB0128499D0/en not_active Ceased
-
2002
- 2002-11-27 DE DE60219672T patent/DE60219672T2/de not_active Expired - Lifetime
- 2002-11-27 US US10/497,002 patent/US20060040940A1/en not_active Abandoned
- 2002-11-27 AT AT02779772T patent/ATE360004T1/de not_active IP Right Cessation
- 2002-11-27 AU AU2002343110A patent/AU2002343110B2/en not_active Ceased
- 2002-11-27 WO PCT/GB2002/005337 patent/WO2003048132A1/en not_active Ceased
- 2002-11-27 EP EP02779772A patent/EP1451161B1/de not_active Expired - Lifetime
- 2002-11-27 CA CA002468893A patent/CA2468893A1/en not_active Abandoned
- 2002-11-27 JP JP2003549324A patent/JP2005518369A/ja active Pending
- 2002-11-27 ES ES02779772T patent/ES2284941T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005518369A (ja) | 2005-06-23 |
| DE60219672T2 (de) | 2007-12-27 |
| AU2002343110B2 (en) | 2008-10-30 |
| EP1451161A1 (de) | 2004-09-01 |
| DE60219672D1 (de) | 2007-05-31 |
| WO2003048132A1 (en) | 2003-06-12 |
| GB0128499D0 (en) | 2002-01-23 |
| AU2002343110A1 (en) | 2003-06-17 |
| CA2468893A1 (en) | 2003-06-12 |
| EP1451161B1 (de) | 2007-04-18 |
| ES2284941T3 (es) | 2007-11-16 |
| US20060040940A1 (en) | 2006-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE360004T1 (de) | Imidazopyridine, -pyrimidine und -triazine als gaba-a alpha 5 rezeptor subtyp liganden zur verbesserung kognitiver eigenschaften | |
| RU2309951C2 (ru) | Производные никотинамида, способы их получения, фармацевтическая композиция на их основе и применение | |
| AR037682A1 (es) | Derivados de acetileno que tienen actividad antagonista para receptores glutamato metabotropico humanos, composicion farmaceutica, una combinacion y el uso de dichos derivados para la fabricacion de composiciones farmaceuticas | |
| EA200201179A1 (ru) | Производные 2-аминокарбонил-9h-пурина | |
| DK1261602T3 (da) | Imidazol-2-carboxamidderivater som Raf-kinaseinhibitorer | |
| BR0314392A (pt) | Composto ou um sal do mesmo, composição farmacêutica, uso de um composto, método de tratamento e/ou profilaxia de uma doença inflamatória e/ou alérgica ou deficiência cognitiva em um mamìfero, e, combinação | |
| ATE139233T1 (de) | Annelierte thiophen-derivate, ihre herstellung und verwendung | |
| BR0212760A (pt) | Compostos quìmicos | |
| HK1041257A1 (zh) | 作為nk-3受體拮抗劑的喹啉-4-酰胺衍生物 | |
| BG107171A (bg) | Производни на пурин | |
| AR035935A1 (es) | El empleo de un antagonista del receptor de nk-1 y una composicion farmaceutica que lo comprende | |
| RU2008112691A (ru) | Азотсодержащее гетероциклическое соединение и его фармацевтическое применение | |
| EA200000700A3 (ru) | НОВЫЕ β- КАРБОЛИНОВЫЕ СОЕДИНЕНИЯ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ИХ | |
| DE602004012758D1 (de) | Chinoxalinderivate als inhibitoren der neutrophilelastase und deren verwendung | |
| BRPI0506848A (pt) | composto,uso do mesmo, formulação farmacêutica e produto farmacêutico | |
| ATE530182T1 (de) | Pharmazeutische zubereitungen enthaltend nk1- rezeptoren antagonisten und natriumkanal blockierende verbindungen | |
| TR200000727T2 (tr) | 5HT geri alım inhibitörü ve h5-HT1B antagonistinin bir bileşimi. | |
| WO2005040345A3 (en) | 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase | |
| EA200401455A1 (ru) | Производные бензоксазина в качестве модуляторов 5-htи их применение | |
| DE60014394D1 (de) | Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha | |
| MX2012008147A (es) | Derivados de pirrazolopiridina. | |
| AR059490A1 (es) | Cmpuestos antivirales heterociclicos | |
| TW200510320A (en) | Aminoquinoline derivatives and their use as adenosine A3 ligands | |
| AR037611A1 (es) | Compuestos derivados de amino-tetralina, su uso, un procedimiento para su preparacion y composiciones farmaceuticas que los comprenden | |
| EA200301171A1 (ru) | Новые соединения трициклических дигидрохинолинов, способ их получения и фармацевтические композиции, содержащие их |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |